the results indicated that this level in the gastric cancer patients ( 26.53 +/- 23.11 ) was markedly higher than that in patients with benign gastric diseases ( 4.66 +/- 2.67 ) and controls ( 2.57 +/- 2.67 ) .
C0024623
gastric cancer
C0038351
gastric